VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 20 filers reported holding VASCULAR BIOGENICS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $8,000 | -69.2% | 6,911 | -64.8% | 0.00% | – |
| Q3 2019 | $26,000 | -42.2% | 19,612 | -43.8% | 0.00% | – |
| Q2 2019 | $45,000 | +114.3% | 34,900 | +149.3% | 0.00% | – |
| Q1 2019 | $21,000 | -80.6% | 14,000 | -79.0% | 0.00% | – |
| Q3 2018 | $108,000 | +5300.0% | 66,640 | +16560.0% | 0.00% | – |
| Q4 2017 | $2,000 | – | 400 | +100.0% | 0.00% | – |
| Q2 2017 | $0 | – | 200 | +100.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 100 | -98.6% | 0.00% | – |
| Q2 2016 | $33,000 | +94.1% | 7,394 | +41.4% | 0.00% | – |
| Q1 2016 | $17,000 | +240.0% | 5,230 | +390.2% | 0.00% | – |
| Q4 2015 | $5,000 | -28.6% | 1,067 | +6.7% | 0.00% | – |
| Q3 2015 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |